Martin Tenniswood

Founder at miR Scientific LLC

Health Technology

Profile

Martin Tenniswood is associated with miR Scientific LLC as the founder and has held the title of Chief Scientific Officer since the company's founding in 2014.

Martin Tenniswood active positions

Companies	Position	Start
miR Scientific LLC miR Scientific LLC BiotechnologyHealth Technology miR Scientific LLC is an American healthcare company that specializes in the early and accurate detection, characterization, and monitoring of urological cancers. The private company has developed a proprietary, non-invasive platform called the miR Disease Management Platform®, which powers the miR Sentinel™ Prostate Cancer Test. This liquid biopsy urine test accurately detects, classifies, and monitors prostate cancer based on the interrogation of sncrnas extracted from non-dre urinary exosomes. The company is developing interoperable products and services to revolutionize the standards of care supporting urologic oncology. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in the United States with operating subsidiaries in Puerto Rico. The company was founded in 2014 by Rob Tenniswood, Martin Tenniswood, and Sam Salman. Sam Salman has been the CEO since 2014.	Founder	01/01/2014

All active positions of Martin Tenniswood

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin Tenniswood's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
miR Scientific LLC miR Scientific LLC BiotechnologyHealth Technology miR Scientific LLC is an American healthcare company that specializes in the early and accurate detection, characterization, and monitoring of urological cancers. The private company has developed a proprietary, non-invasive platform called the miR Disease Management Platform®, which powers the miR Sentinel™ Prostate Cancer Test. This liquid biopsy urine test accurately detects, classifies, and monitors prostate cancer based on the interrogation of sncrnas extracted from non-dre urinary exosomes. The company is developing interoperable products and services to revolutionize the standards of care supporting urologic oncology. miR Scientific is a majority-owned operating subsidiary of Impact NRS LLC, headquartered in the United States with operating subsidiaries in Puerto Rico. The company was founded in 2014 by Rob Tenniswood, Martin Tenniswood, and Sam Salman. Sam Salman has been the CEO since 2014.	Health Technology